← Back to catalogue

Simplexa™ GBS Direct

FDA UDI

Class II (US FDA UDI)

by DiaSorin Molecular LLC

Identity

Trade Name
Simplexa™ GBS Direct FDA UDI
Generic Name
Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Model / Reference
MOL3550 FDA UDI

Identifiers

Catalog Number
MOL5290 FDA UDI
Primary DI / UDI-DI
20816101025644 FDA UDI
510(k) Number
K182467 FDA UDI
FDA Product Code
OOI FDA UDI
NJR FDA UDI
GMDN Term
Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.2570 FDA UDI
866.3740 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Thermal cycler nucleic acid amplification analyser IVD, laboratoryBeta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)

Simplexa™ GBS Direct by DiaSorin Molecular LLC — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT).

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 673cf3f7-9c76-4074-9fb8-2c80fad6de42 36 fields · synced Jun 9, 2026